{
    "clinical_study": {
        "@rank": "52052", 
        "arm_group": [
            {
                "arm_group_label": "phenolics form orange peel, type 1", 
                "arm_group_type": "Active Comparator", 
                "description": "1 dose of 500 mg of phenolics from orange peel, orally ingested"
            }, 
            {
                "arm_group_label": "phenolics from orange peel, type 2", 
                "arm_group_type": "Active Comparator", 
                "description": "1 dose of 500 mg of phenolics from orange peel, orally ingested"
            }, 
            {
                "arm_group_label": "phenolics from orange peel, type 3", 
                "arm_group_type": "Experimental", 
                "description": "1 dose of 500 mg of phenolics from orange peel, orally ingested"
            }
        ], 
        "brief_summary": {
            "textblock": "In this study, the bioavailability of a specific orange peel extract is tested. The\n      composition and morphology of the test product is altered compared to the generic product,\n      which is used as a control. Due to intellectual property issues, more information cannot be\n      given at this moment. Also the difference in bioavailability between a capsule and a lozenge\n      is tested. The hypothesis is that the bioavailability of the altered extract will be\n      improved compared to the control."
        }, 
        "brief_title": "Assessment of Bioavailability of Phenolics From an Orange Peel Extract", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": "Improving Bioavailability", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  healthy adults\n\n          -  BMI 18.5 to 25\n\n        Exclusion Criteria:\n\n          -  pregnancy\n\n          -  smoking\n\n          -  alcohol or drug abuse\n\n          -  use of medication\n\n          -  use of nutritional supplements\n\n          -  abnormal liver or kidney function"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "11", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 9, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02033330", 
            "org_study_id": "Cordiart-PKA-1"
        }, 
        "intervention": {
            "arm_group_label": [
                "phenolics form orange peel, type 1", 
                "phenolics from orange peel, type 2", 
                "phenolics from orange peel, type 3"
            ], 
            "intervention_name": "phenolics form orange peel", 
            "intervention_type": "Dietary Supplement"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "phenolics", 
            "orange peel", 
            "bioavailability"
        ], 
        "lastchanged_date": "January 9, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Maastricht", 
                    "country": "Netherlands", 
                    "zip": "6229ER"
                }, 
                "name": "Maastricht University Medical Centre"
            }
        }, 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_arms": "3", 
        "official_title": "Assessment of Bioavailability of Phenolics From an Orange Peel Extract", 
        "overall_official": {
            "affiliation": "MUMC", 
            "last_name": "Chris Van der Grinten, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "plasma concentrations of specific phenolics and their metabolites", 
            "safety_issue": "No", 
            "time_frame": "up to 24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02033330"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "urine concentrations of specific phenolics and their metabolites", 
            "safety_issue": "No", 
            "time_frame": "24 hours"
        }, 
        "source": "Maastricht University Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Maastricht University Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}